Related Experiment Videos

Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome

Magda R Hamczyk1,2, Lara del Campo1,2, Vicente Andrés1,2

  • 1Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain;

Annual Review of Physiology
|September 22, 2017
PubMed

Insights

Aging significantly increases cardiovascular disease (CVD) risk. Research on Hutchinson-Gilford progeria syndrome (HGPS) reveals mechanisms linking progerin to accelerated aging and CVD, offering insights into normal aging processes.

Area of Science:

  • Cardiovascular Science
  • Aging Research
  • Genetics

Background:

  • Aging is the primary risk factor for cardiovascular disease (CVD).
  • Hutchinson-Gilford progeria syndrome (HGPS) accelerates aging and CVD due to a progerin mutation.
  • Atherosclerosis and heart failure are major contributors to age-related CVD mortality.

Purpose of the Study:

  • To understand how aging promotes cardiovascular disease.
  • To explore mechanisms of accelerated aging and CVD in HGPS.
  • To identify potential therapeutic targets for age-related CVD.

Main Methods:

  • Review of structural and functional cardiovascular changes in physiological and premature aging.
  • Discussion of mechanisms involving prelamin A and progerin in CVD.
  • Analysis of HGPS as a model for studying normal aging processes.

Main Results:

  • Progerin causes severe atherosclerosis and cardiac electrophysiological alterations in HGPS.
  • HGPS exhibits hallmarks of normal aging, suggesting shared underlying mechanisms.
  • Pre-lamin A and progerin contribute to cardiovascular aging in both HGPS and normal aging.

Conclusions:

  • Understanding HGPS mechanisms can illuminate pathways of physiological cardiovascular aging.
  • Targeting progerin-related pathways may offer strategies to mitigate age-associated CVD.
  • Further research into prelamin A and progerin is crucial for developing interventions against CVD and aging.

Related Concept Videos